Semiallogeneic cell hybrids as therapeutic vaccines for cancer.

Newton, D A; Romano, C; Gattoni-Celli, S

Newton, D A; Romano, C; Gattoni-Celli, S.

Affiliation

Newton DA; Department of Radiation Oncology, Hollings Cancer Center, Medical University of South Carolina, Charleston 29403, USA.

J Immunother ; 23(2): 246-54, 2000.

Article in En | MEDLINE | ID: mdl-10746551

Subject(s)

Cancer Vaccines/immunology; Cancer Vaccines/therapeutic use; Hybrid Cells/transplantation; Adenocarcinoma/immunology; Adenocarcinoma/secondary; Adenocarcinoma/therapy; Carcinoembryonic Antigen/biosynthesis; Humans; Hybrid Cells/immunology; Immunotherapy, Adoptive/methods; Lymphocytes, Tumor-Infiltrating/immunology; Melanoma/immunology; Melanoma/secondary; Melanoma/therapy; Tumor Cells, Cultured

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cancer Vaccines / Hybrid Cells Limits: Humans Language: En Journal: J Immunother Year: 2000 Document type: Article

Search on Google

XML

PubMed Links